Since 1995, VasoMedical has developed cardiovascular therapy and diagnostic technology, beginning with EECP systems and expanding into ambulatory monitoring and cloud-based cardiac analysis. Its current work pairs non-invasive EECP treatment with the ARCS Cloud platform, which helps high-volume ECG teams review data and produce reports. The company also owns Biox Instruments and has maintained China-based manufacturing and R&D since expanding its portfolio in 2010.